4 hours Ago By Defense World Staff
Stephens reiterated their equal weight rating on shares of Paragon 28 ( NYSE:FNA – Free Report ) in a research report report published on Thursday morning, MarketBeat reports. They currently have a $13.00 target price on the stock, down from their prior target price of $14.
00. FNA has been the subject of several other research reports. William Blair lowered Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday.
Needham & Company LLC reiterated a “hold” rating and issued a $13.00 price objective on shares of Paragon 28 in a report on Wednesday. Finally, Canaccord Genuity Group reissued a “hold” rating on shares of Paragon 28 in a research report on Wednesday.
Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $14.60.
Read Our Latest Stock Analysis on FNA Paragon 28 Stock Performance Paragon 28 ( NYSE:FNA – Get Free Report ) last posted its earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.
16) by $0.01. Paragon 28 had a negative net margin of 25.
31% and a negative return on equity of 37.90%. The firm had revenue of $62.
30 million during the quarter, compared to analysts’ expectations of $60.58 million. During the same period last year, the company posted ($0.
10) EPS. The company’s quarterly revenue was up 18.0% compared to the same quarter last year.
As a group, research analysts expect that Paragon 28 will post -0.64 earnings per share for the current year. Insider Buying and Selling In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 72,133 shares of the business’s stock in a transaction on Friday, November 22nd.
The stock was sold at an average price of $10.16, for a total value of $732,871.28.
Following the sale, the insider now directly owns 10,559,065 shares of the company’s stock, valued at approximately $107,280,100.40. The trade was a 0.
68 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link . Insiders have sold 300,192 shares of company stock worth $3,135,086 in the last 90 days.
Insiders own 15.32% of the company’s stock. Hedge Funds Weigh In On Paragon 28 Several institutional investors and hedge funds have recently modified their holdings of the stock.
State Street Corp increased its stake in Paragon 28 by 2.6% during the 3rd quarter. State Street Corp now owns 1,563,331 shares of the company’s stock valued at $10,443,000 after purchasing an additional 39,075 shares in the last quarter.
Geode Capital Management LLC grew its holdings in shares of Paragon 28 by 2.5% during the third quarter. Geode Capital Management LLC now owns 967,519 shares of the company’s stock valued at $6,464,000 after buying an additional 23,167 shares during the last quarter.
JPMorgan Chase & Co. increased its position in shares of Paragon 28 by 2,141.7% during the third quarter.
JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after acquiring an additional 749,865 shares in the last quarter. Millennium Management LLC raised its holdings in Paragon 28 by 5,834.
0% in the 2nd quarter. Millennium Management LLC now owns 725,489 shares of the company’s stock worth $4,962,000 after acquiring an additional 713,263 shares during the last quarter. Finally, Wellington Management Group LLP lifted its position in Paragon 28 by 7.
0% in the 3rd quarter. Wellington Management Group LLP now owns 694,799 shares of the company’s stock valued at $4,641,000 after acquiring an additional 45,215 shares in the last quarter. 63.
57% of the stock is currently owned by institutional investors. Paragon 28 Company Profile ( Get Free Report ) Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Read More Five stocks we like better than Paragon 28 Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains What Are Dividend Achievers? An Introduction Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead Top Biotech Stocks: Exploring Innovation Opportunities Beyond Self-Driving Cars: Factory Automation Takes Center Stage Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter ..
